Found: 45
Select item for more details and to access through your institution.
Early phase clinical studies of AR‐42, a histone deacetylase inhibitor, for neurofibromatosis type 2‐associated vestibular schwannomas and meningiomas.
- Published in:
- Laryngoscope Investigative Otolaryngology, 2021, v. 6, n. 5, p. 1008, doi. 10.1002/lio2.643
- By:
- Publication type:
- Article
Quadruplet therapy for newly diagnosed myeloma: comparative analysis of sequential cohorts with triplet therapy lenalidomide, bortezomib and dexamethasone (RVd) versus daratumamab with RVD (DRVd) in transplant-eligible patients.
- Published in:
- Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-01120-9
- By:
- Publication type:
- Article
Prophylactic tocilizumab to prevent cytokine release syndrome (CRS) with teclistamab: A single-center experience.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00963-y
- By:
- Publication type:
- Article
Twice‐weekly ixazomib in combination with lenalidomide‐dexamethasone in patients with newly diagnosed multiple myeloma.
- Published in:
- British Journal of Haematology, 2018, v. 182, n. 2, p. 231, doi. 10.1111/bjh.15394
- By:
- Publication type:
- Article
Lenalidomide and vorinostat maintenance after autologous transplant in multiple myeloma.
- Published in:
- British Journal of Haematology, 2015, v. 171, n. 1, p. 74, doi. 10.1111/bjh.13527
- By:
- Publication type:
- Article
The Novel Deacetylase Inhibitor AR-42 Demonstrates Pre-Clinical Activity in B-Cell Malignancies In Vitro and In Vivo.
- Published in:
- PLoS ONE, 2010, v. 5, n. 6, p. 1, doi. 10.1371/journal.pone.0010941
- By:
- Publication type:
- Article
Characterization of multiple myeloma vesicles by label-free relative quantitation.
- Published in:
- Proteomics, 2013, v. 13, n. 20, p. 3013, doi. 10.1002/pmic.201300142
- By:
- Publication type:
- Article
Elotuzumab directly enhances NK cell cytotoxicity against myeloma via CS1 ligation: evidence for augmented NK cell function complementing ADCC.
- Published in:
- Cancer Immunology, Immunotherapy, 2013, v. 62, n. 12, p. 1841, doi. 10.1007/s00262-013-1493-8
- By:
- Publication type:
- Article
Development of a method for clinical pharmacokinetic testing to allow for targeted Melphalan dosing in multiple myeloma patients undergoing autologous transplant.
- Published in:
- British Journal of Clinical Pharmacology, 2020, v. 86, n. 11, p. 2165, doi. 10.1111/bcp.14308
- By:
- Publication type:
- Article
Population pharmacokinetics of lenalidomide in patients with B‐cell malignancies.
- Published in:
- British Journal of Clinical Pharmacology, 2019, v. 85, n. 5, p. 924, doi. 10.1111/bcp.13873
- By:
- Publication type:
- Article
Multiple myeloma immunoglobulin lambda translocations portend poor prognosis.
- Published in:
- Nature Communications, 2019, v. 10, n. 1, p. N.PAG, doi. 10.1038/s41467-019-09555-6
- By:
- Publication type:
- Article
Tailoring Microstructure and Properties of Hierarchical Aluminum Metal Matrix Composites Through Friction Stir Processing.
- Published in:
- JOM: The Journal of The Minerals, Metals & Materials Society (TMS), 2012, v. 64, n. 2, p. 234, doi. 10.1007/s11837-012-0249-9
- By:
- Publication type:
- Article
Initial genome sequencing and analysis of multiple myeloma.
- Published in:
- Nature, 2011, v. 471, n. 7339, p. 467, doi. 10.1038/nature09837
- By:
- Publication type:
- Article
Divergence of variant antibodies following SARS-CoV-2 booster vaccines in myeloma and impact of hybrid immunity.
- Published in:
- NPJ Vaccines, 2024, v. 9, n. 1, p. 1, doi. 10.1038/s41541-024-00999-6
- By:
- Publication type:
- Article
Chemotherapeutic Agents Increase the Risk for Pulmonary Function Test Abnormalities in Patients With Multiple Myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2012, v. 12, n. 5, p. 325, doi. 10.1016/j.clml.2012.06.002
- By:
- Publication type:
- Article
Ixazomib maintenance therapy in newly diagnosed multiple myeloma: An integrated analysis of four phase I/II studies.
- Published in:
- European Journal of Haematology, 2019, v. 102, n. 6, p. 494, doi. 10.1111/ejh.13231
- By:
- Publication type:
- Article
Predictive value of clinical lacunar syndromes for lacunar infarcts onmagnetic resonance brain imaging.
- Published in:
- Acta Neurologica Scandinavica, 2000, v. 101, n. 1, p. 13, doi. 10.1034/j.1600-0404.2000.00003.x
- By:
- Publication type:
- Article
Phase II evaluation of paclitaxel in combination with carboplatin in advanced head and neck carcinoma.
- Published in:
- 2001
- By:
- Publication type:
- journal article
Autologous hematopoietic stem cell transplant induces the molecular aging of T-cells in multiple myeloma.
- Published in:
- Bone Marrow Transplantation, 2015, v. 50, n. 10, p. 1379, doi. 10.1038/bmt.2015.143
- By:
- Publication type:
- Article
The hematopoietic stem cell transplant comorbidity index can predict for 30-day readmission following autologous stem cell transplant for lymphoma and multiple myeloma.
- Published in:
- Bone Marrow Transplantation, 2014, v. 49, n. 10, p. 1323, doi. 10.1038/bmt.2014.155
- By:
- Publication type:
- Article
Central nervous system post-transplant lymphoproliferative disorder despite negative serum and spinal fluid Epstein–Barr virus DNA PCR.
- Published in:
- 2007
- By:
- Publication type:
- Letter
Ex vivo expansion of umbilical cord blood stem cells for transplantation: growing knowledge from the hematopoietic niche.
- Published in:
- Bone Marrow Transplantation, 2007, v. 39, n. 1, p. 11, doi. 10.1038/sj.bmt.1705538
- By:
- Publication type:
- Article
Retrospective utility of bronchoscopy after hematopoietic stem cell transplant.
- Published in:
- Bone Marrow Transplantation, 2006, v. 38, n. 10, p. 693, doi. 10.1038/sj.bmt.1705505
- By:
- Publication type:
- Article
Evaluating the Impacts of CYP3A4*1B and CYP3A5*3 Variations on Pharmacokinetic Behavior and Clinical Outcomes in Multiple Myeloma Patients With Autologous Stem Cell Transplant.
- Published in:
- Cancer Genomics & Proteomics (1109-6535), 2023, v. 20, n. 1, p. 9, doi. 10.21873/cgp.20360
- By:
- Publication type:
- Article
Phase I ficlatuzumab monotherapy or with erlotinib for refractory advanced solid tumours and multiple myeloma.
- Published in:
- British Journal of Cancer, 2014, v. 111, n. 2, p. 272, doi. 10.1038/bjc.2014.290
- By:
- Publication type:
- Article
A phase 1 trial of the histone deacetylase inhibitor AR-42 in patients with neurofibromatosis type 2-associated tumors and advanced solid malignancies.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2021, v. 87, n. 5, p. 599, doi. 10.1007/s00280-020-04229-3
- By:
- Publication type:
- Article
Pharmacokinetic‐Pharmacodynamic Model of Neutropenia in Patients With Myeloma Receiving High‐Dose Melphalan for Autologous Stem Cell Transplant.
- Published in:
- CPT: Pharmacometrics & Systems Pharmacology, 2018, v. 7, n. 11, p. 748, doi. 10.1002/psp4.12345
- By:
- Publication type:
- Article
Eliminating the monitoring period with subcutaneous daratumumab: a single-center experience.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00801-1
- By:
- Publication type:
- Article
Eliminating the monitoring period with subcutaneous daratumumab: a single-center experience.
- Published in:
- 2023
- By:
- Publication type:
- Letter
Venetoclax ex vivo functional profiling predicts improved progression-free survival.
- Published in:
- Blood Cancer Journal, 2022, v. 12, n. 8, p. 1, doi. 10.1038/s41408-022-00710-9
- By:
- Publication type:
- Article
Downregulation of PA28α induces proteasome remodeling and results in resistance to proteasome inhibitors in multiple myeloma.
- Published in:
- Blood Cancer Journal, 2020, v. 10, n. 12, p. 1, doi. 10.1038/s41408-020-00393-0
- By:
- Publication type:
- Article
Gain of Chromosome 1q is associated with early progression in multiple myeloma patients treated with lenalidomide, bortezomib, and dexamethasone.
- Published in:
- Blood Cancer Journal, 2019, v. 9, n. 12, p. 1, doi. 10.1038/s41408-019-0254-0
- By:
- Publication type:
- Article
Circulating miRNA markers show promise as new prognosticators for multiple myeloma.
- Published in:
- Leukemia (08876924), 2014, v. 28, n. 9, p. 1922, doi. 10.1038/leu.2014.155
- By:
- Publication type:
- Article
CS1-specific chimeric antigen receptor (CAR)-engineered natural killer cells enhance in vitro and in vivo antitumor activity against human multiple myeloma.
- Published in:
- Leukemia (08876924), 2014, v. 28, n. 4, p. 917, doi. 10.1038/leu.2013.279
- By:
- Publication type:
- Article
Impact of concurrent gabapentin or pregabalin with high‐dose melphalan in patients with multiple myeloma undergoing autologous hematopoietic stem cell transplant.
- Published in:
- Pharmacotherapy, 2022, v. 42, n. 3, p. 233, doi. 10.1002/phar.2667
- By:
- Publication type:
- Article
XRCC1‐mediated DNA repair is associated with progression‐free survival of multiple myeloma patients after autologous stem cell transplant.
- Published in:
- Molecular Carcinogenesis, 2019, v. 58, n. 12, p. 2327, doi. 10.1002/mc.23121
- By:
- Publication type:
- Article
Polymorphism in ANRIL is associated with relapse in patients with multiple myeloma after autologous stem cell transplant.
- Published in:
- Molecular Carcinogenesis, 2017, v. 56, n. 7, p. 1722, doi. 10.1002/mc.22626
- By:
- Publication type:
- Article
Serum free light chains in myeloma patients with an intact M protein by immunofixation: potential roles for response assessment and prognosis during induction therapy with novel agents.
- Published in:
- Hematological Oncology, 2012, v. 30, n. 3, p. 156, doi. 10.1002/hon.1019
- By:
- Publication type:
- Article
TTP disease course is independent of myeloma treatment and response.
- Published in:
- American Journal of Hematology, 2010, v. 85, n. 4, p. 304, doi. 10.1002/ajh.21646
- By:
- Publication type:
- Article
CYP3A5 influences oral tacrolimus pharmacokinetics and timing of acute kidney injury following allogeneic hematopoietic stem cell transplantation.
- Published in:
- Frontiers in Pharmacology, 2024, p. 1, doi. 10.3389/fphar.2023.1334440
- By:
- Publication type:
- Article
Daratumumab in multiple myeloma.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Survival outcomes of patients with primary plasma cell leukemia (pPCL) treated with novel agents.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Composition and structure of nitrogen-containing dispersoids in trimodal aluminum metal–matrix composites.
- Published in:
- Journal of Materials Science, 2010, v. 45, n. 17, p. 4871, doi. 10.1007/s10853-010-4571-8
- By:
- Publication type:
- Article
Early lexical development in German: a study on vocabulary growth and vocabulary composition during the second and third year of life.
- Published in:
- 2002
- By:
- Publication type:
- Journal Article
Characterizing Pain Experiences: African American patients with multiple myeloma taking around-the-clock opioids.
- Published in:
- Clinical Journal of Oncology Nursing, 2020, v. 24, n. 5, p. 538, doi. 10.1188/20.CJON.538-546
- By:
- Publication type:
- Article